It's curtain close for Spotlight: Gene editing biotech shutters Incyte pens $885M biobucks AI pact to use Genesis' GEMS to develop new drugs Deep Track nominates candidates for Dynavax's board, launching proxy fight to end company's 'empire-building' strategy Altitude Lab sources funding, lab space for biotechs concerned about fate of NIH grants IconOVir, 4 years on from flashy launch, sells oncolytic virus to UroGen for $4M in stock UPDATE: RFK Jr. says HHS is 'bringing back common sense' with new messaging on 'biological truth' German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals Flourish Research makes deal with Diablo to acquire the California-based clinical research facility | 